When "a little tough" becomes the norm. Suspected Behçet's disease

When you lose your ordinary daily life.Even when you feel something is a bit off,you are so busy with your hectic daily life ...
Medscape

Infliximab vs Adalimumab: Which Is Best for Behçet Syndrome?

Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet syndrome, with adalimumab demonstrating a quicker response time; both drugs ...
Nature

Behçet's Disease Epidemiology and Clinical Management articles from across Nature Portfolio

Behçet’s disease (BD) is an inflammatory autoimmune disease characterized by relapsing genital ulcers, ocular involvement, and intestinal disorders. Evaluate serum levels of circular RNA (circRNA) ...
Medscape

Behçet's Syndrome Prevalence Nearly Doubles in England Over Two Decades

Prevalence of Behçet's syndrome (BS) in England nearly doubled between 2001 and 2021, while incidence remained stable. Among core clinical features, genital ulceration was associated with the shortest ...
Yahoo Finance

Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease

PRINCETON, N.J., July 31, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Healio

Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine

Please provide your email address to receive an email when new articles are posted on . Adalimumab plus corticosteroids significantly outperformed cyclosporine plus corticosteroids to delay Behçet’s ...
EurekAlert!

2025 update for Behçet’s syndrome

The EULAR recommendations for the management of Behçet’s syndrome were first published in 2008, and updated in 2018. Since that time, new evidence has become available, including trials of biologic ...
Nasdaq

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease

PRINCETON, N.J., March 26, 2026 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

Can We Have Hope for Behcet's Disease Too? I Studied a Little About So-Called 'Animal Therapy'

Hello. I am Hiro, a licensed psychologist.I have an intractable disease called Behcet's disease, and I am attacked daily by ...
Nasdaq

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Yahoo Finance

Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...